中基長壽科學(00767.HK)曾挫逾六成 遭聯交所指未有足夠業務運作保證股份續上市
中基長壽科學(00767.HK)今日(20日)早段股價一度插63.4%低見0.086元,最新報0.112元,跌52.3%,成交6,385萬股,涉資696萬元。公司公布,上周五(17日)聯交所就其所作決定向公司發出函件,當中表示公司未能維持上市規則所要求之足夠業務運作以保證其股份可繼續上市,並將根據上市規則暫停公司股份買賣。
聯交所認為,中基長壽科學2021年之前,P2P業務及借貸業務為其主要業務。公司決定於2020年終止P2P業務,而借貸業務於2019年開始下滑,並於2021年上半年跌至最低水準。公司試圖依靠長壽科學業務以滿足上市規則。然而,該業務的經營歷史較短,目前經營規模較小。該業務十分依賴公司執行董事兼董事會主席閆立,其擴張計劃缺乏細節,並不可信。聯交所認為公司未能證明其擁有可行及可持續的實質性業務。
此外,聯交所指中基長壽科學的借貸業務缺乏業務實質,經營水準較低;諮詢業務及物業投資業務的經營規模較小,公司並無提供該等業務的具體計劃等。
聯交所指出,公司須重新符合上市規則之規定,履行聯交所可能制定之任何復牌指引及全面遵守上市規則且獲聯交所信納後,方可恢復股份買賣。倘連續18個月暫停買賣,聯交所或會撤銷公司股份之上市地位。
公司已決定於下周三(29日)或之前提出要求將該決定轉交上市委員會覆核,公司正在編製有關要求函件。因此,提出覆核該決定的要求後,公司股份將繼續買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.